|
2024 Journal Article Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killingPham, Amy, Tan, Kellynn K. Y., Ledger, Emma L., Smith, Daniel J., Reid, David W., Burr, Lucy, Chambers, Daniel C. and Wells, Timothy J. (2024). Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing. Frontiers in Cellular and Infection Microbiology, 14 1426773. doi: 10.3389/fcimb.2024.1426773 |
|
2024 Journal Article Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis RegistryWebb, Elizabeth M., Holland, Anne E., Chang, Anne B., Burr, Lucy, Holmes-Liew, Chien-Li, King, Paul T., Middleton, Peter G., Morgan, Lucy, Thomson, Rachel M., Wong, Conroy and Lee, Annemarie L. (2024). Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry. Respiratory Medicine, 233 107777, 107777. doi: 10.1016/j.rmed.2024.107777 |
|
2024 Journal Article Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasisSajiir, Haressh, Wong, Kuan Yau, Müller, Alexandra, Keshvari, Sahar, Burr, Lucy, Aiello, Elena, Mezza, Teresa, Giaccari, Andrea, Sebastiani, Guido, Dotta, Francesco, Ramm, Grant A., Macdonald, Graeme A., McGuckin, Michael A., Prins, Johannes B. and Hasnain, Sumaira Z. (2024). Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis. Nature Communications, 15 (1) 4527, 1-12. doi: 10.1038/s41467-024-48320-2 |
|
2024 Journal Article Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitisSajiir, Haressh, Keshvari, Sahar, Wong, Kuan Yau, Borg, Danielle J., Steyn, Frederik J., Fercher, Christian, Taylor, Karin, Taylor, Breten, Barnard, Ross T., Müller, Alexandra, Moniruzzaman, Md, Miller, Gregory, Wang, Ran, Fotheringham, Amelia, Schreiber, Veronika, Sheng, Yong Hua, Hancock, Janelle Louise, Loo, Dorothy, Burr, Lucy, Huynh, Tony, Lockett, Jack, Ramm, Grant A., Macdonald, Graeme A., Prins, Johannes B., McGuckin, Michael A. and Hasnain, Sumaira Z. (2024). Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis. Nature Communications, 15 (1) 4528, 4528. doi: 10.1038/s41467-024-48317-x |
|
2024 Journal Article Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trialChang, Anne B., Yerkovich, Stephanie T., Baines, Katherine J., Burr, Lucy, Champion, Anita, Chatfield, Mark D., Eg, Kah P, Goyal, Vikas, Marsh, Robyn L, McCallum, Gabrielle B, McElrea, Margaret, McPhail, Steven, Morgan, Lucy C, Morris, Peter S, Nathan, Anne M, O’Farrell, Hannah, Sanchez, Marion O, Parsons, Marianne, Schultz, André, Torzillo, Paul J, West, Nicholas P, Versteegh, Lesley, Marchant, Julie M and Grimwood, Keith (2024). Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trial. BMJ Open Respiratory Research, 11 (1) e002216, e002216. doi: 10.1136/bmjresp-2023-002216 |
|
2024 Journal Article Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialFeigl, Beatrix, Lewis, Simon J.G., Burr, Lucy D., Schweitzer, Daniel, Gnyawali, Subodh, Vagenas, Dimitrios, Carter, Drew D. and Zele, Andrew J. (2024). Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial. eClinicalMedicine, 69 102474, 102474. doi: 10.1016/j.eclinm.2024.102474 |
|
2024 Journal Article Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trialBennett, Chijioke, Woo, Wayne, Bloch, Mark, Cheung, King, Griffin, Paul, Mohan, Rahul, Deshmukh, Sachin, Arya, Mark, Cumming, Oscar, Neville, A Munro, McCallum Pardey, Toni G, Plested, Joyce S, Cloney-Clark, Shane, Zhu, Mingzhu, Kalkeri, Raj, Patel, Nita, Marcheschi, Alex, Swan, Jennifer, Smith, Gale, Cho, Iksung, Glenn, Gregory M, Walker, Robert, Mallory, Raburn M, Anderson, Anna, Ang, Mary, Barnes, Timothy, Bassin, Michelle, Bessey, Kate, Bowler, Simon ... Young, Rhys (2024). Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial. The Lancet Infectious Diseases, 24 (6), 581-593. doi: 10.1016/S1473-3099(24)00077-X |
|
2023 Journal Article The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variantPegg, Cassandra L., Modhiran, Naphak, Parry, Rhys H., Liang, Benjamin, Amarilla, Alberto A., Khromykh, Alexander A., Burr, Lucy, Young, Paul R., Chappell, Keith, Schulz, Benjamin L. and Watterson, Daniel (2023). The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant. Glycobiology, 34 (2) cwad097, 1-13. doi: 10.1093/glycob/cwad097 |
|
2023 Journal Article Elevated BMI reduces the humoral response to SARS‐CoV‐2 infectionTong, Marcus Z. W., Sng, Julian D. J., Carney, Meagan, Cooper, Lucy, Brown, Samuel, Lineburg, Katie E., Chew, Keng Yih, Collins, Neve, Ignacio, Kirsten, Airey, Megan, Burr, Lucy, Joyce, Briony A., Jayasinghe, Dhilshan, McMillan, Christopher L. D., Muller, David A., Adhikari, Anurag, Gallo, Linda A., Dorey, Emily S., Barrett, Helen L., Gras, Stephanie, Smith, Corey, Good‐Jacobson, Kim and Short, Kirsty R. (2023). Elevated BMI reduces the humoral response to SARS‐CoV‐2 infection. Clinical and Translational Immunology, 12 (12) e1476, 1-13. doi: 10.1002/cti2.1476 |
|
2023 Journal Article Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina cladesPham, Amy, Volmer, James G., Chambers, Daniel C., Smith, Daniel J., Reid, David W., Burr, Lucy and Wells, Timothy J. (2023). Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina clades. Frontiers in Microbiology, 14 1274280, 1-14. doi: 10.3389/fmicb.2023.1274280 |
|
2023 Journal Article The impact of long-term macrolide exposure on the gut microbiome and its implications for metabolic controlChoo, Jocelyn M., Martin, Alyce M., Taylor, Steven L., Sun, Emily, Mobegi, Fredrick M., Kanno, Tokuwa, Richard, Alyson, Burr, Lucy D., Lingman, Stevie, Martin, Megan, Keating, Damien J., Mason, A. James and Rogers, Geraint B. (2023). The impact of long-term macrolide exposure on the gut microbiome and its implications for metabolic control. Microbiology Spectrum, 11 (4). doi: 10.1128/spectrum.00831-23 |
|
2023 Journal Article Subjective and objective sleep quality does not predict behavioural episodic foresight in younger or older adultsDemichelis, Olivia P., Grainger, Sarah A., McKay, Kate T., Burr, Lucy, Kim, Joanne and Henry, Julie D. (2023). Subjective and objective sleep quality does not predict behavioural episodic foresight in younger or older adults. Scientific Reports, 13 (1) 1056, 1-10. doi: 10.1038/s41598-023-28183-1 |
|
2023 Journal Article ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation settingLee, Annemarie L., Smith, Rebecca, Burr, Lucy, Chang, Anne B., Holmes‐Liew, Chien‐Li, King, Paul, Middleton, Peter, Morgan, Lucy, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and McAleer, Rachael (2023). ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation setting. The Clinical Respiratory Journal, 17 (1), 59-69. doi: 10.1111/crj.13563 |
|
2023 Journal Article GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infectionFoo, Cheng Xiang, Bartlett, Stacey, Chew, Keng Yih, Ngo, Minh Dao, Bielefeldt-Ohmann, Helle, Jayakody Arachchige, Buddhika, Matthews, Benjamin, Reed, Sarah, Wang, Ran, Smith, Christian, Sweet, Matthew J., Burr, Lucy, Bisht, Kavita, Shatunova, Svetlana, Sinclair, Jane E., Parry, Rhys, Yang, Yuanhao, Lévesque, Jean-Pierre, Khromykh, Alexander, Rosenkilde, Mette Marie, Short, Kirsty R. and Ronacher, Katharina (2023). GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection. European Respiratory Journal, 61 (3) 2201306, 1-15. doi: 10.1183/13993003.01306-2022 |
|
2023 Journal Article Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trialsUluer, Ahmet Z, MacGregor, Gordon, Azevedo, Pilar, Indihar, Veronica, Keating, Claire, Mall, Marcus A, McKone, Edward F, Ramsey, Bonnie W, Rowe, Steven M, Rubenstein, Ronald C, Taylor-Cousar, Jennifer L, Tullis, Elizabeth, Yonker, Lael M, Chu, Chenghao, Lam, Anna P, Nair, Nitin, Sosnay, Patrick R, Tian, Simon, Van Goor, Fredrick, Viswanathan, Lakshmi, Waltz, David, Wang, Linda T, Xi, Yingmei, Billings, Joanne, Horsley, Alexander, Nash, Edward F., Bakker, Marleen, van der Meer, Renske, Merkus, Petrus ... Wilson, John (2023). Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11 (6), 550-562. doi: 10.1016/S2213-2600(22)00504-5 |
|
2022 Journal Article Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator eraDavidson, Sarah J., France, Megan, Callaway, Leonie K., Lust, Karin, Chambers, Daniel, Hopkins, Peter, Bell, Scott C., Burr, Lucy, Keating, Rebecca and Barrett, Helen L. (2022). Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. Obstetric Medicine, 16 (4), 217-221. doi: 10.1177/1753495x221146342 |
|
2022 Journal Article Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence TaskforceWhite, Heath, McDonald, Steve J, Barber, Bridget, Davis, Joshua, Burr, Lucy, Nair, Priya, Mukherjee, Sutapa, Tendal, Britta, Elliott, Julian, McGloughlin, Steven and Turner, Tari (2022). Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce. Medical Journal of Australia, 217 (7), 368-378. doi: 10.5694/mja2.51718 |
|
2022 Journal Article Carriage and transmission of macrolide resistance genes in patients with chronic respiratory conditions and their close contactsWang, Yiming, Taylor, Steven L., Choo, Jocelyn M., Papanicolas, Lito E., Keating, Rebecca, Hindmarsh, Kate, Thomson, Rachel M., Morgan, Lucy, Rogers, Geraint B. and Burr, Lucy D. (2022). Carriage and transmission of macrolide resistance genes in patients with chronic respiratory conditions and their close contacts. Chest, 162 (1), 56-65. doi: 10.1016/j.chest.2022.01.045 |
|
2022 Journal Article Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung diseaseRigauts, Charlotte, Aizawa, Juliana, Taylor, Steven L., Rogers, Geraint B., Govaerts, Matthias, Cos, Paul, Ostyn, Lisa, Sims, Sarah, Vandeplassche, Eva, Sze, Mozes, Dondelinger, Yves, Vereecke, Lars, Van Acker, Heleen, Simpson, Jodie L., Burr, Lucy, Willems, Anne, Tunney, Michael M., Cigana, Cristina, Bragonzi, Alessandra, Coenye, Tom and Crabbé, Aurélie (2022). Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. European Respiratory Journal, 59 (5) 2101293, 1-16. doi: 10.1183/13993003.01293-2021 |
|
2022 Journal Article Assessment of long-term macrolide exposure on the oropharyngeal microbiome and macrolide resistance in healthy adults and consequences for onward transmission of resistanceBurr, Lucy D., Taylor, Steven L., Richard, Alyson, Schreiber, Veronika, Lingman, Stevie, Martin, Megan, Papanicolas, Lito E., Choo, Jocelyn M. and Rogers, Geraint B. (2022). Assessment of long-term macrolide exposure on the oropharyngeal microbiome and macrolide resistance in healthy adults and consequences for onward transmission of resistance. Antimicrobial Agents and Chemotherapy, 66 (4) ARTN e02246-21. doi: 10.1128/aac.02246-21 |
